Efficacy and Safety of JTT-705 300, 600 And 900mg in Comparison With Placebo in Patients With Type II Hyperlipidaemia

Inclusion Criteria: * Patients with of Type II hyperlipidaemia * Patients having lipid values as indicated below: * HDL-C \< 1.6 mmol/l * TG \< 4.5 mmol/l * Male and females between 18 and 65 years old (If female must be post-menopausal, or pre-menopausal and surgically sterile or using an acceptable form of contraception) Exclusion Criteria: * Body Mass Index (BMI) \> 35 kg/m² * Pregnant, breast feeding, or woman with child bearing potential without an effective method of contraception * Concomitant use of medications identified in the protocol